See the leaked documents and other materials from the documentary “Second Opinion: Laetrile At Sloan-Kettering”

June 2, 1974 Laetrile Meeting with Top Leaders (Minutes)

On June 2, 1974 a meeting was held at The Food & Drug Administration (FDA) headquarters. The meeting’s purpose was to discuss conducting human clinical trials using Laetrile or similar “cyanide-releasing” substances based on the overwhelmingly positive lab studies conducted by Sloan-Kettering’s Dr. Kanematsu Sugiura.

These minutes were obtained via a “Freedom of Information Act” request.

Read: June 2, 1974 Minutes from Laetrile meeting at the FDA

After all attempts to get the attention of  mainstream journalists using these leaked documents, Ralph W. Moss, PhD packaged the documents up and sent them anonymously to “The Committee For Freedom Of Choice In Cancer Therapy” – which continued to distribute them in an attempt to alert the American public of this cover-up.

Read the leaked documents package here.

1977 Second Opinion Special Report: Laetrile At Sloan-Kettering

This 48-page document was written in the summer of 1977 by Ralph W. Moss, PhD and other anonymous rank-in-file employees of Sloan-Kettering. This report was written in response to the alleged “negative” findings of Sloan-Kettering’s Laetrile studies from 1973-1977. This document was also given to all in attendance of the November 1977 press conference held by Second Opinion.

Read the “Second Opinion Special Report: Laetrile At Sloan-Kettering Special” document here.

November 22, 1977 Letter to Second Opinion from Dr. Kanematsu Sugiura

While Ralph W. Moss, PhD was still an anonymous participant in Second Opinion, he sent his evaluation of Sloan-Kettering’s papers on their Laetrile studies (Special Report on Laetrile) to Dr. Sugiura, who was the lead scientist conducting the studies. This letter is Dr. Sugiura’s response to Ralph’s evaluation of his work and how Sloan-Kettering diabolically manipulated the positive data. The letter is addressed to Alec Pruchnicki, the only public “face” of Second Opinion at this time.

Read the Nov. 22, 1977 letter to Second Opinion from Dr. Sugiura

July 30, 1979 letter from Dr. Kanematsu Sugiura

Shortly after the release of this documentary, the film’s director was contacted by a man named John Pittman Hey, who had written to Dr. Sugiura regarding the laetrile cover-up back in 1979—and Dr. Sugiura responded. This is a very special and rare letter, and Mr. Hey has given us permission to post it here. It’s incredible how focused Dr. Sugiura was even at this late age – and how he steadfastly stood behind the results he found while testing Laetrile at Sloan-Kettering. It also shows what kind of man Dr. Sugiura was to write a handwritten 4-page letter to a total stranger. He wrote this letter 3 months before his death.

Read the July 30, 1979 letter from Dr. Sugiura to Mr. Hey

 

October 24, 1979 Letter to Ralph W. Moss, PhD from Linus Pauling

After Ralph was fired for exposing the Laetrile cover-up at Sloan-Kettering, he wrote a book about his experience called The Cancer Rebellion: Hope and Betrayal, that was to eventually become The Cancer Industry. Linus Pauling had some very strong words towards “The War On Cancer”.

Read the letter from Linus Pauling to Ralph W. Moss

1971 Congressional Testimony from the NCI’s Dr. Dean Burk

*This document is not included in Second Opinion, but it gives some insight to the political climate around Laetrile when the War On Cancer was first enacted. This is congressional testimony by Dr. Dean Burk, the head of the National Cancer Institute’s Cytochemistry Sector, with Congressman Symington.

Read the 1971 Congressional Testimony with Dr. Burk and Rep. Symington

 

German studies confirm Laetrile/Amygdalin’s anti-cancer properties

Watch the Q&A from “Second Opinion” here:

 

 

Read the peer-reviewed publications here:

August 2014:

Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0105590

 

Amygdalin Influences Bladder Cancer Cell Adhesion and InvasionIn Vitro

October 2014: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0110244

 

Challenge for the reader, try adding these verifiable links to the Wikipedia page for “Amygdalin” – they will not allow it! (Click here).

 

Maybe this is why 🙂 Watch this amazing TEDx lecture below:

 

 

Eric Merola releases “Second Opinion: Laetrile At Sloan-Kettering”

Eric Merola releases “Second Opinion: Laetrile At Sloan-Kettering” in 5 cities theatrically, and not a peep from Sloan-Kettering.

See the Change.org petition.

 

 

WATCH INSTANTLY on VHX for $4.99

Television | Print | Radio

TV:

September 3, 2014
CBS’s internationally syndicated TV show, “The Doctors”

 

September 19, 2014
KATU-TV, Portland, OR – Live interview with Eric Merola and Ralph Moss

[hr]

PRINT REVIEWS:

“Though a documentary, it’s dramatic enough to be reminiscent of ‘The Insider’, the whistleblowing thriller about Big Tobacco.”

—Graham Fuller, New York Daily News August 28, 2014

“Mr. Moss’s message is clear, shrewdly edited and peculiarly interesting.”

—Anita Gates, New York TimesAugust 28, 2014

“an intriguing tale”

—Robert Abele, Los Angeles Times, September 4, 2014

“‘has the production value of a Hollywood whistle-blower thriller”

The Stranger, Seattle WA, September 18, 2014

“‘Second Opinion’ revives stifled testing of cancer drug”

San Francisco Chronicle, September 10, 2014

“unraveling the threads of a contested cancer treatment”

San Francisco Weekly, September 10, 2014

“See this film for a riveting account of the conflicts between corporate power and the public good.”

Counter Punch – August 29, 2014

Interview with Ralph W. Moss and Eric Merola
— Robyn Candyce, Moviehole.net – September 2, 2014 

“Captivating story”
This Week In New York – August 31, 2014

“‘Nobody is going to pay $70,000 for a new cancer drug if they can buy Laetrile for 75 cents.” There you have it.”
Reel Life with Jane – August 31, 2014

“this is a worthy piece of work.”
Hollywood Report Card

“riveting…absorbing study of men who sold out science at a renowned institution” 
Anthony Liversidge, New Movies New York – August 31, 2014

“shocking … eye-opening expose’ confirming your worst fears”
Kam Williams – August 30, 2014

“A fascinating, eye-opening and enraging exposé”
NYC Movie Guru – August 29, 2014

“Disturbing … what happens when language must be turned inside out”
Pop Matters – August 29, 2014

“eye-opening documentary”
Turkish New York, September 9, 2014

“Portrait of a thoughtful, articulate, and courageous whistle-blower.”
Spirituality and Practice – August 28, 2014

Second Opinion reveals something astonishingly tragic in the annals of medical history”
Film Journal International – August 27, 2014

“educate[s] viewers of the immense political and economic control that works to determine
what is considered conventional medicine”

Latino Weekly – August 27, 2014

“Concisely presents an interesting and often overlooked chapter of recent American history”
Tiny Mixed Tapes – August 26, 2014

“This intelligent film … may be a renewed eye on the power of pharmaceuticals and their lobbies.”
It’s Just Movies – August 21, 2014

“Eric Merola delivers a documentary that both inspires and astounds.” 
Stage Buddy – August 19, 2014

“A powerful and enlightening documentary that is sure to resonate with audiences” 
Life In LA – August 14, 2014

[hr]

RADIO:

KSJS FM  – 90.5 FM – Celluloid Dreams – San Jose, CA
September 16, 2014 (Eric Merola ad Ralph Moss)

KGO-AM Review with Andrea Chase, San Francisco
September 16, 2014

97.3 FM interview with Eric Merola and Ralph Moss, Liz Saint John, San Francisco
September 14, 2014

Film School Radio: Los Angeles
September 5, 2014 (Eric Merola)

KPFK-FM Radio: Los Angeles, Santa Barbara, San Diego, Ridgecrest.
September 3, 2014 (Eric Merola)

KGO-AM Radio, San Francisco
September 1, 2014 (Ralph W. Moss)

Dr. Ronald Hoffman Podcast (Part 1 of 2) August 29, 2014

Dr. Ronald Hoffman Podcast (Part 2 of 2) August 29, 2014

Leonard Lopate Radio Show (NPR / WNYU) – New York City
August 27, 2014 (Ralph W. Moss)

LISTEN

Coast2Coast Radio – Worldwide
August 26, 2014 
(Ralph W. Moss)

WSPU / NPR / PBS radio interview with Ralph W. Moss, PhD
May 30, 2014 – State College, PA
[ listen ]

[hr]

MORE:

September 18, 2014
Eric Merola and Ralph W. Moss, PhD on Bulletproof Radio with Dave Asprey

March 6, 2014
Q&A session with Director Eric Merola and Ralph W. Moss, PhD


[hr]

Eric Merola – IMDB Biography

Eric Merola is an internationally award-winning documentary film director.

Before starting his career in documentary films, Eric began as a motions graphics designer and animator after founding “Merola Productions” and was commissioned by various clients including Fuel TV, WE Network, The Speed Channel, and Rolling Stone’s Matt Taibbi. He was also employed as an animation director for FlickerLab in New York City, where he worked on projects for Comedy Central and A&E.

In 2007, while directing an animated sequence for Michael Moore’s feature documentary, “Capitalism: A Love Story“, Eric began production on his first documentary, “Burzynski”, which garnered widespread distribution and won numerous international awards including “Best Documentary of 2011” on The Documentary Channel, two “Audience Awards” at the HumanDoc Film Festival in Warsaw and the “Humanitarian Vision Award” at the Newport Beach Film Festival. This film also received favorable reviews from various press including The Los Angeles Times and Variety, and granted Mr. Merola a guest appearance on The Dr. Oz Show.

Eric has since released a sequel to “Burzynski” in 2013 (“Burzynski: Cancer Is Serious Business, Part II“), which garnered even larger world-wide distribution, and took home the top Audience Award for Best Documentary at the Sedona Film Festival on March 2, 2014. While working on this sequel, he was also shooting and directing his third documentary, “Second Opinion: Laetrile At Sloan-Kettering“, which will have a theatrical release starting in eight major USA cities in the summer of 2014.

Visit Eric Merola Biography page on IMDB here. 

<blockquote class=”twitter-tweet” lang=”en”><p>Congratulations to Eric Merola, director of <a href=”https://twitter.com/hashtag/Burzynski?src=hash”>#Burzynski</a&gt; <a href=”https://twitter.com/hashtag/Cancer?src=hash”>#Cancer</a&gt; is Serious Business for winning the Audience Award from BEST of <a href=”https://twitter.com/DOC_Channel”>@DOC_Channel</a&gt;!</p>&mdash; Documentary Channel (@DOC_Channel) <a href=”https://twitter.com/DOC_Channel/statuses/156420405211561984″>January 9, 2012</a></blockquote>
<script async src=”//platform.twitter.com/widgets.js” charset=”utf-8″></script>

New York Times – About Eric Merola

Eric Merola, Director & Producer – Bio (New York Times)

Eric Merola is an internationally award-winning documentary film director.

Before starting his career in documentary films, Eric began as a motions graphics designer and animator after founding Merola Productions and was commissioned by various clients including Fuel TV, WE Network, The Speed Channel, and Rolling Stone’s Matt Taibbi. He was also employed as an animation director for FlickerLab in New York City, where he worked on projects for Comedy Central and A&E.

In 2007, while directing an animated sequence for Michael Moore’s feature documentary, “Capitalism: A Love Story”, Eric began production on his first documentary, BURZYNSKI, which garnered widespread distribution and won numerous international awards including “Best Documentary of 2011” on The Documentary Channel, two “Audience Awards” at the HumanDoc Film Festival in Warsaw and the “Humanitarian Vision Award” at the Newport Beach Film Festival. This film also received favorable reviews from various press including The Los Angeles Times and Variety, and granted Mr. Merola a guest appearance on The Dr. Oz Show.

Eric has since released a sequel to BURZYNSKI in 2013, which also garnered world-wide distribution and won the top Audience Choice Award for Best Documentary at the Sedona International Film Festival on March 2, 2014. While working on this sequel, he was also shooting and directing his third documentary, SECOND OPINION: LAETRILE AT SLOAN-KETTERING.

FOLLOW ERIC MEROLA ON FACEBOOK

ericmerola.com

 

eric_merola_photo_google

Eric Merola’s company website and bio: http://merolaproductions.com/eric-merola-bio/

Eric’s main website: http://ericmerola.com/

Eric Merola bio on Second Opinion: http://www.secondopinionfilm.com/eric-merola-director-biography

Eric Merola | 2014: March 31 Radio interview PRN.FM

Podcast: Play in new window | Download | Embed

In Episode 6 of “The Infectious Myth” David Crowe interviews Eric Merola, director of three documentaries on people going outside the mainstream on cancer. The first two documentaries are Burzynski, the Movie (2010) and Burzynski: Cancer is Serious Business, Part II (2013), both on Dr. Buzynski of Houston, who has battled for decades with the US FDA to get his non-toxic antineoplastons accepted as a legal cancer therapy. The most recent film, Second Opinion (2014), is about the discovery of Ralph Moss, then in Public Relations at Sloan Kettering Memorial Cancer Centre, that Laetrile was effective in cancer treatment, and that he was supposed to be putting our press releases containing lies.

David and Eric talk about how the highly profitable nature of mainstream cancer therapy distorts the purpose of cancer treatment from helping victims of cancer, to maintaining the profitable status quo. Eric implies that the cancer establishment will have to crumble before major changes in what is allowed for cancer treatment will change in any substantial way in the United States. And that will only occur with a grass-roots revolt against the continuing War on Cancer. This decades only titanic struggle pits toxic treatments against tumors with the cancer patient’s body as the battlefield. Even if the patient doesn’t die in the process of all out war, they may wonder if it was worth it at the end.

Dr. Burzynski’s antineoplastons are natural proteins that he found were present in lower quantities in many cancer patients. He does not claim a perfect success rate, but his successes in previously intractable cases, such as many brain tumors, are vastly greater than the mainstream. Similarly, laetrile is no magic bullet, but it has been scientifically show to have some benefits. Which is more, Merola points out, that can be said for mainstream cancer treatments, which are lightly studied for one type of cancer before approval, and then widely used “off label” after approval.

David describes the current cancer treatment system as a tumor with only one aim – to maintain it’s own viability. Like all tumors, it is vulnerable to a change in the environment. And this is where all individuals who educate themselves become antineoplastons (anti-cancer-agents).

For more information on how you can watch Merola’s documentaries, see http://ericmerola.com